Axiom MRC has updated all it's market research reports with the Economic Impact Analysis of COVID19 Pandemic on the market. Our team of analyst are following Comprehensive Three Dimensional (3D) Research Methodology along with large number primary interviews with key industry participants to bring insightful market reports to meet the current market requirements.
The changing dynamics worldwide, and growing burden of different diseases like Infectious Diseases, Oncology among other have growing requirement for different testing procedure further to opt for treatment. These further create requirement for different laboratories to get the result outcomes. The molecular quality controls market finds its major opportunity for improving the testing process resulting in error free results with precise results. The market helps in processes, performance and identification. The growing requirement for different molecular quality controls market in the different clinical laboratories, hospitals among others is expected to drive the growth of market during the estimated time period.
The market is driven by increasing number of accredited clinical laboratories across the globe. The rising burden of different diseases worldwide, and growing requirement for molecular quality controls in testing has significantly increased the demand for market. Also, accredited clinical laboratories are ideally verified laboratories that mostly provide the laboratories results with confidence thereby these laboratories have increasing requirement for molecular quality controls which is likely to contribute in the growth of market during the forecast period. Also, growing adoption of third-party quality controls and rising demand for external quality assessment support are propelling the growth of market to huge extent.
The exclusive COVID 19 impact analysis report by Axiom MRC provides a 360 degree analysis of micro and macro-economic factors on the molecular quality controls market. In addition, complete analysis of changes on the molecular quality controls market expenditure, economic and international policies on supply and demand side. The report also studies the impact of pandemic on global economies, international trade, business investments, GDP and marketing strategies of key players present in the market. The COVID-19 pandemic has provided a positive growth for market as number of laboratories were having increasing requirement molecular quality controls products.
The molecular quality controls market comprises of different market segment like product, analyte type, application, end users and geography
By product, the molecular quality controls market includes key segment of independent controls, instrument-specific controls. Instrument-specific Controls segment further includes PCR, DNA Sequencing & NGS and Other Technologies. Independent controls is expected to dominate in the market during the forecast period. It helps the laboratory to enhance the performance with unbiased, independent assessment. Also, the independent controls bring the testing to level of standardization and uniformity which is ideally needed in the different laborites testing. Likewise, instrument-specific controls is likely to contribute healthy growth in the market during the estimated time period.
The molecular quality controls market, includes different analyte type like single-analyte controls, multi-analyte controls. Multi-analyte controls dominated the market in 2020 and is expected to witness emerging growth during the forecast period (2021-2027). The factors contributing in the market growth are wide range of formats which majorly enhance the flexibility for user including controls, and assayed or unassayed versions. Also, it accurately monitor the assay performance, helps in troubleshoot error, control entire testing process among others. Furthermore, single-analyte controls is expected to grow at moderate pace during the estimated time period.
The molecular quality controls market finds its major application in infectious diseases, oncology, genetic testing and others. Infectious diseases has gained major shares for the molecular quality controls market attributing to increasing burden of different infectious diseases like HIV, HAI, Hepatitis , ToRCH, lyme disease, COVID-19 and many others has led the demand for different products of molecular quality controls market. Furthermore, the products provides an ability for testing with precise results, error free thereby is expected to witness increasing demand infectious diseases segment. On the other hand, oncology is expected to hold second position in market as the different cancer burden worldwide has growing number of patient testing to identify the type of cancer, early detection which has led the rising demand for the market.
The molecular quality controls market has different end user like clinical laboratories, hospitals, ivd manufacturers & cros, academic and research institutes. Clinical laboratories has gained major market for the global molecular quality controls market. The growing patient sample for testing for early detection of diseases has led the rising demand for the segment. Furthermore, in clinical laboratories, quality control is one of the major aspect for precise laboratories resulting reducing the error in testing. Additionally, hospitals is expected to witness increasing demand for market as number of hospital are implementing laboratories services for diagnosis of patient sample thereby the market finds its major opportunity in the segment.
The global molecular quality controls market is studied for the following region North America, Europe, Asia-Pacific and Rest of the world (RoW). North America is expected to register major market share during the forecast period. The developed healthcare infrastructure and rising new clinical laboratories across the region is driving the growth of market. Besides, growing patient burden in different diseases like cancer, infectious diseases has led the growing demand for market. Furthermore, presence of key manufacturer in the region is the key accelerating the market growth. Also, Europe is anticipated to hold second position in the market owing to increasing for Molecular Quality Controls products which can further provide an ability for early detection of diseases. Additionally, rising demand for external quality assessment support for Molecular Quality Controls Market has increased the growth of Europe region. However, Asia Pacific is expected to witness the growth at highest pace during the projection period.
The key players in molecular quality controls market are Seracare Life Sciences Inc., Thermo Fisher Scientific, Bio-Rad Laboratories, Microbiologics Inc., Zeptometrix, Roche Diagnostics, Abbott Laboratories, Quidel, Qnostics and Maine Molecular Quality Controls Inc. among others.
June 2021: LGC SeraCare had expanded its line of SARS-CoV-2 molecular quality solutions to include AccuPlex SARS-CoV-2 Variant Panel 1. The kit contains full SARS-CoV-2 genomic RNA with a focus on S-gene mutations in three prominent variants of concern with vials.
March 2021: The Abbott Laboratories had announced U.S. Food and Drug Administration (FDA) Emergency Use Authorization (EUA) for the company's Alinity m Resp-4-Plex molecular assay to detect and differentiate SARS-CoV-2, influenza A, influenza B and respiratory syncytial virus (RSV) in one test. Alinity m uses Polymerase Chain Reaction (PCR) technology, which is known for its high sensitivity in detecting infectious diseases.
May 2020: ZeptoMetrix had announced the development and release of a ready-to-use SARS-CoV-2 molecular quality control formulated with purified intact viral particles that have been chemically modified to render them non-infectious and refrigerator stable
July 2018: Quidel had announced that it received 510(k) clearance from the United States Food and Drug Administration (FDA) to market its Solana Bordetella Complete Assay, a molecular diagnostic assay to be used with the Solana molecular diagnostic instrument for the qualitative detection and differentiation of Bordetella pertussis and Bordetella parapertussis nucleic acids isolated from nasopharyngeal swab specimens obtained from patients suspected of having a respiratory tract infection.
The report analyses the molecular quality controls market based on by product, analyte type, application, end users and geography. By product, the molecular quality controls market includes key segment of independent controls, instrument-specific controls. Independent controls is expected to dominate in the market during the forecast period. The molecular quality controls market, includes different analyte type like single-analyte controls, multi-analyte controls. Multi-analyte controls dominated the market in 2020 and is expected to witness emerging growth during the forecast period (2021-2027). The molecular quality controls market finds its major application in infectious diseases, oncology, genetic testing and others. Infectious diseases has gained major shares for the molecular quality controls market. The molecular quality controls market has different end user like clinical laboratories, hospitals, ivd manufacturers & cros, academic and research institutes. The global molecular quality controls market is studied for the following region North America, Europe, Asia-Pacific and Rest of the world (RoW).
Why to buy this report:
